Effects of total ginsenosides intervention on anxiety and cognitive function in cancer patients
Psycho-Oncologie · 02.06.2026 · 20 (4)
DOI: 10.18282/po5681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psycho-Oncologie, online erschienen am 02.06.2026. Verfasst von Ying Guo und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Psychological distress and perceived cognitive difficulties are common among patients with cancer and can substantially affect quality of life, particularly in older populations receiving ongoing treatment. This pilot observational study examined changes in anxiety and perceived cognitive function following a short-term total ginsenosides intervention in cancer patients. Twenty patients with malignant disease (mean age 80.5 years) were included based on the availability of complete pre- and post-intervention data. Anxiety was assessed using the Hospital Anxiety and Depression Scale–Anxiety subscale (HADS-A), and subjective cognitive function was evaluated using the PROMIS Cognitive Function Short Form. Pre–post comparisons were conducted using non-parametric methods due to non-normal score distributions. Anxiety scores decreased markedly following the intervention, with mean HADS-A scores declining from 16.25 ± 2.38 to 8.50 ± 2.16 and a median reduction of 8 points (Wilcoxon signed-rank test, p < 0.001). Perceived cognitive function improved concurrently, with PROMIS-CF scores increasing from 11.75 ± 2.38 to 14.75 ± 2.38 and a median change of +3.0 points (p < 0.001). Exploratory correlation analysis demonstrated a moderate negative association between changes in anxiety and changes in perceived cognitive function (Spearman ρ = −0.541, p = 0.0138), suggesting that reductions in emotional distress were often accompanied by improvements in perceived cognitive clarity. The intervention was generally well-tolerated, with no serious adverse events reported. Due to the observational design and small sample size, causality cannot be inferred; however, these findings suggest that total ginsenosides may be associated with concurrent improvements in anxiety and subjective cognitive burden in the supportive care setting, warranting further investigation in controlled studies.
Zitieren
APA
Guo, Y., & Li, W. (2026). Effects of total ginsenosides intervention on anxiety and cognitive function in cancer patients. Psycho-Oncologie, 20(4). https://doi.org/10.18282/po5681
Vancouver
Guo Y, Li W. Effects of total ginsenosides intervention on anxiety and cognitive function in cancer patients. Psycho-Oncologie. 2026;20(4). doi:10.18282/po5681
BibTeX
@article{Guo2026,
author = {Guo, Ying and Li, Weiguang},
title = {Effects of total ginsenosides intervention on anxiety and cognitive function in cancer patients},
journal = {Psycho-Oncologie},
year = {2026},
volume = {20},
number = {4},
doi = {10.18282/po5681}
}
EUVIMED